Onconetix Profit Margin

Onconetix (ONCO) currently reports a profit margin of -1319.55% as of March 2026. That compares with -2914.76% in the prior-year period — up 54.7% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Onconetix's profit margin history and peer comparisons.

Onconetix's profit margin increased from -2914.76% to -1319.55% — a 54.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Onconetix's profit margin of -1319.55% is lower than the Healthcare sector average of 15.29%. That is roughly 8728.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Onconetix's current -1319.55% should be judged against Healthcare norms (sector average: 15.29%) and against ONCO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1319.55%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Onconetix, and consider following ONCO for alerts when major investors trade the stock.